ALSO NOTED: Memory amends Roche collaboration; AMDL closes offering; BioMS gets positive safety review; and much more...

> Memory Pharmaceuticals has amended its PDE4 collaboration with Roche. Release

> AMDL of Tustin, California, has closed its private offering with total gross proceeds of $670,000. Release

> An independent data safety monitoring board has given BioMS Medical a positive safety review for its pivotal MS trial. Release

And Finally… Publisher John Wiley & Sons says it will begin publishing Biotechnology Review, a peer-reviewed industry publication, beginning in January 2006. Story

Suggested Articles

Solid Bio fixed the manufacturing issue that led to a partial clinical hold on its DMD trial, but a full hold remains.

Commissioner Scott Gottlieb has laid out the reasons why he thinks the FDA needs a double-digit budget bump.

GW's cannabis-based epilepsy drug scored a favorable review from FDA staff ahead of an expert panel meeting.